Next Article in Journal / Special Issue
Specifically Targeting Metacaspases of Candida: A New Therapeutic Opportunity
Previous Article in Journal
Transcriptomic Screening of Alternaria oxytropis Isolated from Locoweed Plants for Genes Involved in Mycotoxin Swaisonine Production
Previous Article in Special Issue
SAGA Complex Subunit Hfi1 Is Important in the Stress Response and Pathogenesis of Cryptococcus neoformans
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antigenic Relatedness between Mannans from Coccidioides immitis and Coccidioides posadasii Spherules and Mycelia

by
Amanda R. Burnham-Marusich
1,*,
Kathleen R. Zayac
2,
John N. Galgiani
3,4,5,6,
Lourdes Lewis
3 and
Thomas R. Kozel
2
1
DxDiscovery, Inc., Reno, NV 89557, USA
2
Department of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, NV 89557, USA
3
Valley Fever Center for Excellence, College of Medicine-Tucson, University of Arizona, Tucson, AZ 85721, USA
4
Department of Medicine, College of Medicine-Tucson, University of Arizona, Tucson, AZ 85721, USA
5
Department of Immunobiology, College of Medicine-Tucson, University of Arizona, Tucson, AZ 85721, USA
6
BIO5 Institute, University of Arizona, Tucson, AZ 85721, USA
*
Author to whom correspondence should be addressed.
J. Fungi 2024, 10(2), 89; https://doi.org/10.3390/jof10020089
Submission received: 4 January 2024 / Revised: 17 January 2024 / Accepted: 18 January 2024 / Published: 23 January 2024

Abstract

:
Immunoassays for cell wall mannans that are excreted into serum and urine have been used as an aid in the diagnosis of many disseminated fungal infections, including coccidioidomycosis. Antigen-detection immunoassays are critically dependent on the detection of an analyte, such as mannan, by antibodies that are specific to the analyte. The goal of this study was to evaluate the extent of cross-reactivity of polyclonal antibodies raised against Coccidioides spp. Analysis of antigenic relatedness between mannans from C. posadasii and C. immitis spherules and mycelia showed complete relatedness when evaluated by the method of Archetti and Horsfall, which was originally used to study the antigenic relationships between Influenzae virus isolates. In a further effort to validate the suitability of the antigenic relatedness calculation methodology for polysaccharide antigens, we also applied the method of Archetti and Horsfall to published results that had previously identified the major capsular serotypes of Cryptococcus species. The results of this analysis showed that Archetti and Horsfall’s antigenic relatedness calculation correctly identified the major cryptococcal serotypes. Together, these results suggest that the method is applicable to polysaccharide antigens, and that immunoassays that detect Coccidioides mannans are likely to have good reactivity across Coccidioides species (inclusivity) due to the species’ high level of antigenic relatedness.

1. Introduction

Fungal cell-wall polysaccharides are well-established biomarkers for invasive fungal diseases caused by Ascomycete fungi. Specifically, mannan or galactomannan have been detected in blood or urine from patients with invasive candidiasis [1,2,3], aspergillosis [4,5], blastomycosis [6], fusariosis [7,8], histoplasmosis [9,10], and coccidioidomycosis [11]. In all the above diseases, the detection of shed mannan or galactomannan in the patient specimens was achieved by antigen-detection immunoassay.
The presence of galactomannan (Gm) in the urine of patients with coccidioidomycosis was first noted by Kuberski et al., who found that a Histoplasma antigen test obtained positive results with urine samples from patients with acute or chronic coccidioidomycosis [12]. Subsequent studies generated an immunoassay for the detection of Coccidioides Gm. In these studies, capture and detector antibodies were constructed using serum from rabbits that were immunized with a cocktail of purified C. immitis and C. posadasii Gm and formalin-killed mold [11]. The results showed the presence of Coccidioides Gm in the serum and urine of patients with coccidioidomycosis [11,13,14]. These studies also found that a small number of patients with Coccidioides infection received positive results with a Histoplasma antigen immunoassay. Conversely, a small number of patients with histoplasmosis received positive results with the Coccidioides antigen immunoassay.
The tissue form of Coccidioides spp. in patients is the spherule phase of the fungus, rather than the mycelial form that was used to develop the detection reagents for the original Coccidioides antigen immunoassay. Moreover, coccidioidomycosis is caused by two distinct species, C. immitis and C. posadasii. Successful diagnostics require high clinical sensitivity, for which high inclusivity across both Coccidioides species is a prerequisite. They also require high clinical specificity, meaning low cross-reactivity with other non-Coccidioides fungi. The goal of the present study was to assess the extent of cross-reactivity between mannans from the spherules and mycelia of C. immitis and C. posadasii using serum from immunized rabbits to further our understanding of how best to create diagnostics with the desired inclusivity. We validated the applicability of our methods for fungal carbohydrate antigens by analyzing raw titer data from the seminal studies that identified the major capsular serotypes of Cryptococcus species. Lastly, we also evaluated the reactivity of Coccidioides antisera with mannans from other selected fungi, including Aspergillus fumigatus, Candida albicans, and members of the Mucorales to determine what challenges a Coccidioidies antigen-detection immunoassay would have to surmount to obtain the desired specificity in the clinic.

2. Materials and Methods

2.1. Fungal Cultures

The following fungi were used: Coccidioides immitis (RS) and Coccidioides posadasii (Silveira) from Dr. John Galgiani at the University of Arizona; Aspergillus fumigatus Fresenius (CBS 101355 [AF 293]) from ATCC (Gaithersburg, MD, USA) #MYA-4609; Candida albicans (Robin) Berkhout (SC5314) from ATCC #MYA-2876; Fusarium solani (95-2478) and Rhizopus oryzae (99-892), both from Dr. Ashraf Ibrahim of the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Rhizopus oryzae Went et Prinsen Geerligs (G) from ATCC #46599; Mucor circinelloides f. circinelloides Schipper (C81) from ATCC #8542; and Mucor circinelloides f. circinelloides Schipper (704) from ATCC #8097. All fungi except C. immitis and C. posadasii were cultured in RPMI-1640 (Caisson Labs, Smithfield, UT, USA), supplemented with 2% (w/v) glucose at 37 °C. C. immitis and C. posadasii saprobic-phase cells (mycelia) were grown by adding an arthroconidia spore suspension to a flask containing culture media (RPMI-1640 (Sigma-Aldrich, St. Louis, MO, USA) with L-glutamine and sodium bicarbonate); then, the flask was incubated at 37 °C, at 160 rpm for 96 h. For parasitic-phase cells (spherules), inoculation and growth were as described for mycelia, but the parameters for incubation were: 38 °C, 180 rpm, 20% CO2, and 96 h incubation.

2.2. Mannan Extraction, Purification and Analysis

Fungal mycelia and spherules were harvested by filtration (Whatman #1 filter paper) and centrifugation at 5525× g, respectively, and washed extensively with deionized, 0.22 μm filtered water. Candida albicans blastoconidia were harvested by centrifugation at 4000× g for 5 min and washed with water three times, centrifuging again after each wash. Mannans were extracted through the modification of the hot citrate method of Peat [15]. In brief, the washed fungal cells were collected, weighed, and resuspended in 10 volumes (v/w) of 0.1 M citrate buffer, pH 7.0. The fungal cell suspensions were autoclaved for 25 min. The autoclaved cells were harvested by 0.22 μm filtration or, in the case of Candida cells, by centrifugation, and the supernatant fluid was collected. The washed cells were resuspended in an additional 10 volumes of 0.1 M citrate buffer, pH 7.0 and autoclaved again for 25 min, after which the cells were again separated from the supernatant fluid, as above, and the supernatant fluid was collected. Mannan was purified from the pooled supernatant fluids via affinity chromatography on concanavalin A-Sepharose 4B, dialyzed against water, lyophilized, and weighed.
Mannan compositions were determined by the Complex Carbohydrate Research Center (University of Georgia, Athens, GA, USA). All samples were first subjected to acidic methanolysis. Glycosyl composition analysis was performed via a combined gas chromatography/mass spectrometry (GC/MS) analysis of the per-O-trimethylsilyl derivatives of the monosaccharide methyl glycosides. Protein concentration was determined using the Qubit™ protein assay kit (Invitrogen, Waltham, MA, USA).

2.3. Immunization of Rabbits

The immunization of rabbits for polyclonal antibody production was approved by the University of Nevada, Reno Institutional Animal Care and Use Committee (DxDiscovery IACUC protocol number 20-06-1026-1), and was performed in accordance with relevant guidelines and regulations. All immunizations and the collection of sera were carried out by ProSci, Inc. (Poway, CA, USA). To prepare antigens for the immunization of rabbits, Coccidioides mycelia and spherules were first inactivated by treatment overnight with 1% formalin at room temperature. Formalin-killed mycelia and spherules were washed with water and cultured to ensure inactivation. Fungal cells were then lyophilized, resuspended in endotoxin-free, sterile PBS, and lightly ground with a tissue grinder (Fisherbrand 02-542-09, Fisher Scientific, Waltham, MA, USA) until they could pass through a 22-gauge needle. The immunization protocol was adapted from previous hyperimmunization protocols that were used to generate antibodies to capsular polysaccharides of Cryptococcus species [16,17] and the Group A polysaccharide of Streptococcus pyogenes [18]. Rabbits were intravenously immunized with 0.5 mL of a 2 mg/mL solution of inactivated Coccidioides cells per dose. Doses were delivered every 2–3 days, for a total of 9 doses, which was followed by a rest period of 5 weeks and then a second round of 9 additional doses. Two rabbits were immunized with each antigen preparation. Two weeks following the final dose, animals were euthanized and exsanguinated, and serum was prepared.

2.4. ELISA for the Determination of Antibody Levels

Microtiter plates (655001, Greiner Bio-One, Monroe, NC, USA) were coated overnight with 100 μL of mannan at a concentration of 4 μg/mL in PBS. The plates were then washed with PBS containing 0.05% Tween-20 (PBS-T) and blocked for 90 min with blocking buffer (PBS containing 0.5% Tween-20 and 5% w/v powdered milk). The plates were washed with PBS-T and incubated for 90 min with serial dilutions of rabbit antisera in blocking buffer. The serum dilution series began at 1/4000 and extended through 16 two-fold dilutions. The plates were washed with PBS-T and incubated for 90 min with a 1/5000 dilution of peroxidase-labeled goat anti-rabbit IgG (H+L) (111-035-144, Jackson Immunoresearch, West Grove, PA, USA). Finally, the plates were washed with PBS-T, incubated for 30 min with substrate, and the reaction was stopped through the addition of 1M H3PO4. The absorbance of microtiter wells was read at 450 nm. Endpoint titers were calculated as the serum dilution that produced an OD = 0.5 in a log–log plot of serum dilution vs. OD.

2.5. Calculation of Antigenic Relatedness

Studies of antibody levels are reported as follows: (i) reciprocal antibody titer, (ii) titer ratios, and (iii) antigenic relatedness. Geometric mean titers from each immunization group were used to calculate titer ratios. Titer ratios were calculated as follows: [(geometric mean titer of serum against heterologous mannan)/(geometric mean titer of serum against homologous mannan)]. By definition, the homologous titer ratio is always 1. Antigenic relatedness (r) was calculated according to Archetti and Horsfall as r = (r1 × r2)1/2, where r1 is the titer ratio of the heterologous titer obtained with fungus 2 to the homologous titer obtained with fungus 1 and r2 is the titer ratio of the heterologous titer obtained with fungus 1 to the homologous titer obtained with fungus 2.

3. Results

An initial experiment compared the glycosyl composition and protein content of mannans isolated from C. posadasii and C. immitis mycelia and spherules. The analysis found that all mannans were composed of 3-O-methyl mannose, galactose, mannose, and glucose (Table 1). The 3-O-methylmannose content was approximately three times higher in spherules than in mycelia. Previous studies found that 3-O-methyl mannose was a constituent of extracts from the mycelia of C. immitis [19,20].
The immunization of rabbits with whole mycelia or whole spherules from either C. posadasii or C. immitis led to very high titers of serum antibodies to purified mannans. Every rabbit produced reciprocal titers that exceeded 106. The serum antibody titers for each rabbit in each immunization group, e.g., C. posadasii (Cp) mycelium, C. posadasii spherules, C. immitis (Ci) mycelium, and C. immitis spherules, are shown in Table 2. The results showed extensive cross-reactivity among the various Coccidioides mannans.
The extent of the reciprocal cross-reactivity between the various mannans was determined by the methods of Archetti and Horsfall [21]. In this analysis, the titer ratios for various antisera were calculated as the titer with each heterologous mannan divided by the titer with the homologous mannan (Table 3). A single value that represented the antigenic relationship between mannans from C. immitis or C. posadasii mycelia or spherules was then calculated (Table 4). The results of the antigenic relatedness calculation showed near-identical antigenic relatedness with all antisera and mannans, with relatedness values that ranged from 0.9 to 1.5.
Given the apparent lack of antigenic heterogeneity found with mannans from C. posadasii and C. immitis mycelia and spherules when titers were evaluated using the method of Archetti and Horsfall, we revisited the original reports that identified cryptococcal serotypes A, B, C, and D from 1950 and 1968 [16,17]. The goal was to determine whether the antigenic relatedness calculation of Archetti and Horsfall correctly identified significant antigenic differences among the polysaccharide cryptococcal serotypes that established the four major cryptococcal serotypes. The original studies provide cross-reactivity titers from the sera of rabbits immunized with whole cells of Cryptococcus neoformans. The results from a retrospective analysis of the published cross-reactivity titers showed that the antigenic relatedness calculation using the method of Archetti and Horsfall correctly identified all the distinct cryptococcal serotypes where the classical agglutination of cross-absorbed sera was used for the determination of serotypes (Table 5 and Table 6).
A final experiment examined the reactivity of the antisera raised against C. posadasii and C. immitis mycelia and spherules with mannans of selected fungi. The results (Table 7) showed the extensive reactivity of antisera from rabbits immunized with C. posadasii or C. immitis mycelia with mannans of Aspergillus, Fusarium, R. oryzae 46599, and M. circinelloides 8542. A much lower reactivity was found for the antisera from mycelia-immunized rabbits with mannans of C. albicans, R. oryzae 99-892, and M. circinelloides 8097. The patterns of cross-reactivity induced by mycelia were similar, regardless of whether rabbits were immunized with C. posadasii or C. immitis. In contrast to the considerable cross-reactivity of sera from animals immunized with mycelia, there was very limited reactivity in the antisera from spherule-immunized rabbits with the various non-Coccidioides mannans.

4. Discussion

Coccidioidomycosis is a common cause of community-acquired pneumonia in endemic regions such as southern Arizona and the San Joaquin Valley in California [22]. Approximately 20,000 cases are reported in the U.S. each year, but preliminary studies from the CDC suggest that the actual burden of symptomatic cases may be 6-14 times higher [23]. However, climate change will likely expand the endemic region to include large portions of the western United States [24]. In addition, the number of cases will also increase due to population growth in endemic regions and advances in healthcare that will expand the at-risk population [25].
As the number of cases increases, there will be a need for more effective diagnosis and treatment. Currently, serologic tests are the most commonly used methods for the diagnosis of coccidioidomycosis [26,27]. A limitation to the use of serology is the lag between symptom onset and antibody production [25,27]. In addition, the sensitivity of serology may be lower in immunosuppressed patients [25]. As a consequence, there is an increased interest in antigen detection, which may detect infection at early stages of the disease [11,12,14]. Antigen detection is also useful in the diagnosis of infection in immunocompromised patients. The fungal antigen detected in antigen-detection immunoassay is the cell-wall mannan. A limitation to antigen detection is its low sensitivity in non-immunocompromised patients and cross-reactivity with other dimorphic fungi.
There is an increasing interest in simplifying immunoassays for the diagnosis of coccidioidomycosis. In particular, serologic tests using defined reagents for quantitative enzyme-linked immunoassays and use of the lateral flow immunoassay platform will make serological testing more accessible [28,29,30]. Similarly, the use of an immunoassay for the detection of cell-wall mannan in serum and urine using lateral flow can move laboratory testing closer to the point of patient care [23]. To this end, a major goal in our laboratory is the development of antigen immunoassays in lateral flow format, with increased analytical sensitivity and improved specificity.
The goal of this study was to determine the extent of antigenic relatedness between mannans from mycelia and spherules from representative strains of C. immitis and C. posadasii. The answer is important because immunoassays aiming to diagnose coccidioidomycosis using antigen-detection immunoassays will require: (i) reactivity with mannans from the tissue phase of the fungus, and (ii) an absence of bias in the immunological recognition of mannans from the two species. The results showed that, regardless of the Coccidioides immunogen used, the resulting antisera had complete reactivity across mannans from the two lifeforms and the two major genera (Table 4). This immunologic similarity occurred despite the considerable compositional differences between the mannans (Table 1).
The complete reactivity that is obtained across the Coccidioides mannans likely reflects very strong antigenic relationships, as shown by the use of antisera from immunized rabbits. An alternative explanation is that the antigenic relatedness calculation of Archetti and Horsfall fails to recognize antigenic differences in polysaccharides from pathogenic fungi. Antigenic relatedness was originally used to identify differences between Influenzae viruses and was subsequently used to study the relationships between a variety of viruses.
In an effort to address the ability of the antigenic relatedness calculation to identify antigenic differences among fungal polysaccharides, we reevaluated the original data that first identified the presence of serotypes A, B, and C of Cryptococcus species [16], as well a subsequent report of serotype D [17]. The results (Table 5 and Table 6) showed that the antigenic differences found by the calculation of antigenic relatedness correctly identified all four distinct serotypes found by the use of whole-cell agglutination with cross-adsorbed serum. The congruence of results using these two methods demonstrated that antigenic relatedness can be used with ELISA titers where polysaccharides are used as antigens.
Mannans from spherules and mycelia from C. immitis and C. posadasii are composed of similar carbohydrates, but the quantitative ratios are quite different. All four mannans had mannose and glucose as lesser components (<10%). Galactose (49–73%) and 3-O-methylmannose (10–44%) were major components. Previous studies found very similar compositions in crude extracts from C. immitis arthrospores, mycelium, and spherule cell walls [31]. Our results found the 3-O-methylmannose composition to be three times higher in mannan from C. immitis and C. posadasii spherules than mannan from mycelia, reflecting a likely fundamental difference in the cell-wall compositions of the two life forms. 3-O-methylmannose is an unusual carbohydrate that has been reported as a constituent in polysaccharides from Mycobacteria [32,33] and Coccidioides [19,20,31,34].
Our study evaluated antigenic relatedness as one step in the validation of mannan as a target for an antigen detection immunoassay. Serology has been extensively used as an effective tool in the diagnosis of coccidioidomycosis. We do not know the extent to which the mannans used in the present study would be recognized via the sera from patients with coccidioidomycosis. Nevertheless, our studies demonstrate that the mycelia and spherules of the two species have mannan antigens with close antigenic similarity. This similarity may prove important in further studies of antigen or antibody detection in clinical specimens.
Antigenic relatedness was introduced by Archetti and Horsfall, who used a comparison of reciprocal antibody titers to evaluate the antigenic relatedness of various strains of Influenza A virus [21]. Since that time, antigenic relatedness has been used to analyze and predict vaccine efficacy, and to assess antigenic drift for Influenza virus and other viruses [35,36,37,38,39]. In this type of analysis, the serum titers raised against individual viruses are compared with the homologous immunizing antigens, as well as heterologous antigens. Antigenic relatedness values of 0.5 or less may identify significant differences, e.g., reference [38]. The application of this analysis to antigenic relatedness among mannans of Coccidioides found relatedness values that ranged from 0.9 to 1.5, suggesting a high degree of antigenic similarity between mannans of C. posadasii and C. immitis spherules and mycelia (Table 4), despite the considerable variability in the 3-O-methylmannose content of mannans from mycelia vs. spherules.
Previous studies of immunoassays for Coccidioides mannan in body fluids utilized antigen-detection ELISAs that were constructed using sera from rabbits immunized with C. immitis and C. posadasii galactomannan and mycelia. The extent of cross-reactivity with mannans of other fungi was not reported. However, the results in Table 7 suggest that the specificity of immunoassays constructed from polyclonal rabbit antisera would be optimized by the use of antisera from rabbits immunized with spherules alone. An alternative approach would be construction of antigen immunoassays using monoclonal antibodies of the desired specificity. We are currently working on this approach.

Author Contributions

Conceptualization, A.R.B.-M., J.N.G. and T.R.K.; methodology, A.R.B.-M., K.R.Z. and L.L.; investigation, K.R.Z. and L.L.; formal analysis, K.R.Z., A.R.B.-M. and T.R.K.; writing—original draft preparation, A.R.B.-M. and T.R.K.; writing—review and editing, A.R.B.-M., J.N.G. and T.R.K.; funding acquisition, A.R.B.-M. and T.R.K. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by National Institutes of Health: 75N93022C00028 and 75N93020C00035. The carbohydrate analysis performed at the CCRC was supported by the NIH R24GM137782 grant.

Institutional Review Board Statement

All vertebrate animal work was approved by the University of Nevada, Reno Institutional Animal Care and Use Committee (DxDiscovery IACUC protocol number 20-06-1026-1) and was performed in accordance with relevant guidelines and regulations.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article.

Conflicts of Interest

T.R.K. is a consultant for and a shareholder of DxDiscovery, Inc. A.R.B.-M. is an employee and shareholder of DxDiscovery, Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Jacquinot, P.M.; Plancke, Y.; Sendid, B.; Strecker, G.; Poulain, D. Nature of Candida albicans-derived carbohydrate antigen recognized by a monoclonal antibody in patient sera and distribution over Candida species. FEMS Microbiol. Lett. 1998, 169, 131–138. [Google Scholar] [CrossRef] [PubMed]
  2. Sendid, B.; Tabouret, M.; Poirot, J.L.; Mathieu, D.; Fruit, J.; Poulain, D. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: Useful combined test for diagnosis of systemic candidiasis. J. Clin. Microbiol. 1999, 37, 1510–1517. [Google Scholar] [CrossRef]
  3. Sendid, B.; Poirot, J.L.; Tabouret, M.; Bonnin, A.; Caillot, D.; Camus, D.; Poulain, D. Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J. Med. Microbiol. 2002, 51, 433–442. [Google Scholar] [CrossRef] [PubMed]
  4. Reiss, E.; Lehmann, P.F. Galactomannan antigenemia in invasive aspergillosis. Infect. Immun. 1979, 25, 357–365. [Google Scholar] [CrossRef]
  5. Stynen, D.; Goris, A.; Sarfati, J.; Latgé, J.P. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J. Clin. Microbiol. 1995, 33, 497–500. [Google Scholar] [CrossRef] [PubMed]
  6. Connolly, P.; Hage, C.A.; Bariola, J.R.; Bensadoun, E.; Rodgers, M.; Bradsher, R.W.; Wheat, L.J. Blastomyces dermatitidis antigen detection by quantitative enzyme immunoassay. Clin. Vaccine Immunol. 2012, 19, 53–56. [Google Scholar] [CrossRef] [PubMed]
  7. Mikulska, M.; Furfaro, E.; Del Bono, V.; Gualandi, F.; Raiola, A.M.; Molinari, M.P.; Gritti, P.; Sanguinetti, M.; Posteraro, B.; Bacigalupo, A.; et al. Galactomannan testing might be useful for early diagnosis of fusariosis. Diagn. Microbiol. Infect. Dis. 2012, 72, 367–369. [Google Scholar] [CrossRef] [PubMed]
  8. Tortorano, A.M.; Esposto, M.C.; Prigitano, A.; Grancini, A.; Ossi, C.; Cavanna, C.; Cascio, G.L. Cross-reactivity of Fusarium spp. in the Aspergillus galactomannan enzyme-linked immunosorbent assay. J. Clin. Microbiol. 2012, 50, 1051–1053. [Google Scholar] [CrossRef]
  9. Wheat, L.J.; Kohler, R.B.; Tewari, R.P. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N. Engl. J. Med. 1986, 314, 88. [Google Scholar] [CrossRef]
  10. Connolly, P.A.; Durkin, M.M.; Lemonte, A.M.; Hackett, E.J.; Wheat, L.J. Detection of histoplasma antigen by a quantitative enzyme immunoassay. Clin. Vaccine Immunol. 2007, 14, 1587–1591. [Google Scholar] [CrossRef]
  11. Durkin, M.; Connolly, P.; Kuberski, T.; Myers, R.; Kubak, B.M.; Bruckner, D.; Pegues, D.; Wheat, L.J. Diagnosis of coccidioidomycosis with use of the Coccidioides antigen enzyme immunoassay. Clin. Infect. Dis. 2008, 47, e69–e73. [Google Scholar] [CrossRef] [PubMed]
  12. Kuberski, T.; Myers, R.; Wheat, L.J.; Durkin, M.; Connolly, P.; Kubak, B.M.; Bruckner, D.; Pegues, D. Diagnosis of coccidioidomycosis by antigen detection using cross-reaction with a Histoplasma antigen. Clin. Infect. Dis. 2007, 44, e50–e54. [Google Scholar] [CrossRef] [PubMed]
  13. Durkin, M.; Estok, L.; Hospenthal, D.; Crum-Cianflone, N.; Swartzentruber, S.; Hackett, E.; Wheat, L.J. Detection of Coccidioides antigenemia following dissociation of immune complexes. Clin. Vaccine Immunol. 2009, 16, 1453–1456. [Google Scholar] [CrossRef] [PubMed]
  14. Kassis, C.; Durkin, M.; Holbrook, E.; Myers, R.; Wheat, L. Advances in diagnosis of progressive pulmonary and disseminated coccidioidomycosis. Clin. Infect. Dis. 2021, 72, 968–975. [Google Scholar] [CrossRef] [PubMed]
  15. Peat, S.; Whelan, W.J.; Edwards, T.E. Polysaccharides of baker’s yeast. IV. Mannan. J. Chem. Soc. 1961, 1, 29–34. [Google Scholar] [CrossRef]
  16. Evans, E.E. The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular and agglutination reactions. J. Immunol. 1950, 64, 423–430. [Google Scholar] [CrossRef]
  17. Wilson, D.E.; Bennett, J.E.; Bailey, J.W. Serologic grouping of Cryptococcus neoformans. Proc. Soc. Exper. Biol. Med. 1968, 127, 820–823. [Google Scholar] [CrossRef]
  18. Osterland, C.K.; Miller, E.J.; Karakawa, W.W.; Krause, R.M. Characteristics of streptococcal group-specific antibody isolated from hyperimmune rabbits. J. Exp. Med. 1966, 123, 599–614. [Google Scholar] [CrossRef]
  19. Wheat, R.W.; Woodruff, W.W., III; Haltiwagner, R.S. Occurrence of antigenic (species-specific?) partially 3-O-methylated heteromannans in cell wall and soluble cellular (nonwall) components of Coccidioides immitis mycelia. Infect. Immun. 1983, 41, 728–734. [Google Scholar] [CrossRef]
  20. Cole, G.T.; Kruse, D.; Seshan, K.R. Antigen complex of Coccidioides immitis which elicits a precipitin antibody response in patients. Infect. Immun. 1991, 59, 2434–2446. [Google Scholar] [CrossRef]
  21. Archetti, I.; Horsfall, F.L., Jr. Persistent antigenic variation of influenzae A viruses after incomplete neutralization in ovo with heterologous immune serum. J. Exp. Med. 1950, 92, 441–462. [Google Scholar] [CrossRef] [PubMed]
  22. Valdivia, L.; Nix, D.; Wright, M.; Lindberg, E.; Fagan, T.; Lieberman, D.; Stoffer, T.; Ampel, N.M.; Galgiani, J.N. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg. Infect. Dis. 2006, 12, 958–962. [Google Scholar] [CrossRef] [PubMed]
  23. National Academies of Sciences, Engineering, and Medicine. Impact and control of valley fever. In Proceedings of a Workshop in Brief; The National Academies Press: Washington, DC, USA, 2023. [CrossRef]
  24. Gorris, M.E.; Treseder, K.K.; Zender, C.S.; Randerson, J.T. Expansion of coccidioidomycosis endemic regions in the United States in response to climate change. Geohealth 2019, 3, 308–327. [Google Scholar] [CrossRef] [PubMed]
  25. Williams, S.L.; Chiller, T. Update on the epidemiology, diagnosis, and treatment of coccidioidomycosis. J. Fungi 2022, 8, 666. [Google Scholar] [CrossRef] [PubMed]
  26. Donovan, F.M.; Zangeneh, T.T.; Malo, J.; Galgiani, J.N. Top questions in the diagnosis and treatment of coccidioidomycosis. Open Forum Infect. Dis. 2017, 4, ofx197. [Google Scholar] [CrossRef] [PubMed]
  27. Galgiani, J.N.; Ampel, N.M.; Blair, J.E.; Catanzaro, A.; Geertsma, F.; Hoover, S.E.; Johnson, R.H.; Kusne, S.; Lisse, J.; MacDonald, J.D.; et al. 2016 Infectious Diseases Society of America (IDSA) Clinical practice guideline for the treatment of coccidioidomycosis. Clin. Infect. Dis. 2016, 63, e112–e146. [Google Scholar] [CrossRef] [PubMed]
  28. Wieden, M.A.; Lundergan, L.L.; Blum, J.; Delgado, K.L.; Coolbaugh, R.; Howard, R.; Peng, T.; Pugh, E.; Reis, N.; Theis, J.; et al. Detection of coccidioidal antibodies by 33-kDa spherule antigen, Coccidioides EIA, and standard serologic tests in sera from patients evaluated for coccidioidomycosis. J. Infect. Dis. 1996, 173, 1273–1277. [Google Scholar] [CrossRef] [PubMed]
  29. Donovan, F.M.; Ramadan, F.A.; Khan, S.A.; Bhaskara, A.; Lainhart, W.D.; Narang, A.T.; Mosier, J.M.; Ellingson, K.D.; Bedrick, E.J.; Saubolle, M.A.; et al. Comparison of a novel rapid lateral flow assay to enzyme immunoassay results for early diagnosis of coccidioidomycosis. Clin. Infect. Dis. 2021, 73, e2746–e2753. [Google Scholar] [CrossRef]
  30. Grill, F.J.; Svarovsky, S.; Gonzalez-Moa, M.; Kaleta, E.; Blair, J.E.; Lovato, L.; Grant, R.; Ross, K.; Linnehan, B.K.; Meegan, J.; et al. Development of a rapid lateral flow assay for detection of anti-coccidioidal antibodies. J. Clin. Microbiol. 2023, 61, e0063123. [Google Scholar] [CrossRef]
  31. Wheat, R.W.; Tritschler, C.; Conant, N.F.; Lowe, E.P. Comparison of Coccidioides immitis arthrospore, mycelium, and spherule cell walls, and influence of growth medium on mycelial cell wall composition. Infect. Immun. 1977, 17, 91–97. [Google Scholar] [CrossRef]
  32. Maitra, S.K.; Ballou, C.E. Heterogeneity and refined structtures of 3-O-methyl-D-mannose polysaccharides from Mycobacterium smegmatis. J. Biol. Chem. 1977, 252, 2459–2469. [Google Scholar] [CrossRef] [PubMed]
  33. Gray, G.R.; Ballou, C.E. Isolation and characterization of a polysaccharide containing 3-O-methyl-D-mannose from Mycobacterium phlei. J. Biol. Chem. 1971, 246, 6835–6842. [Google Scholar] [CrossRef] [PubMed]
  34. Cole, G.T.; Kruse, D.; Zhu, S.; Seshan, K.R.; Wheat, R.W. Composition, serologic reactivity, and immunolocalization of a 120-kilodalton tube precipitin antigen of Coccidioides immitis. Infect. Immun. 1990, 58, 179–188. [Google Scholar] [CrossRef]
  35. Gao, J.; Couzens, L.; Burke, D.F.; Wan, H.; Wilson, P.; Memoli, M.J.; Xu, X.; Harvey, R.; Wrammert, J.; Ahmed, R.; et al. Antigenic drift of the influenza A(H1N1)pdm09 virus neuraminidase results in reduced effectiveness of A/California/7/2009 (H1N1pdm09)-specific antibodies. mBio 2019, 10, e00307-19. [Google Scholar] [CrossRef] [PubMed]
  36. Schloer, G. Antigenic relationships among Newcastle disease virus mutants obtained from laboratory strains and from recent California isolates. Infect. Immun. 1974, 10, 724–732. [Google Scholar] [CrossRef]
  37. Ndifon, W.; Dushoff, J.; Levin, S.A. On the use of hemagglutination-inhibition for influenza surveillance: Surveillance data are predictive of influenza vaccine effectiveness. Vaccine 2009, 27, 2447–2452. [Google Scholar] [CrossRef]
  38. Kinjo, T.; Yanagawa, R. Antigenic relationship among strains of infectious canine hepatitis virus. Jpn. J. Vet. Res. 1968, 16, 128–136. [Google Scholar]
  39. Yassine, H.M.; Lee, C.W.; Suarez, D.L.; Saif, Y.M. Genetic and antigenic relatedness of H3 subtype influenza A viruses isolated from avian and mammalian species. Vaccine 2008, 26, 966–977. [Google Scholar] [CrossRef]
Table 1. Composition of purified mannans from different species and growth forms.
Table 1. Composition of purified mannans from different species and growth forms.
Coccidioides Species
and Growth Form
Glycosyl Composition (%) aProtein a
(%)
ArabinoseGalactoseMannoseGlucose3-O-Me-Mannose
C. posadasii mycelia0.3633.315178.6
C. posadasii spherules-491.95.24411
C. immitis mycelia1.8738.16.69.94.4
C. immitis spherules1.2652.23.7287.5
a Glycosyl composition and protein, reported as the percentage of carbohydrate or protein present in dry samples.
Table 2. Cross-reactivity between Coccidioides mannans by ELISA.
Table 2. Cross-reactivity between Coccidioides mannans by ELISA.
Antiserum aRabbit
Number
Mannan b
Cp MyceliaCp SpherulesCi MyceliaCi Spherules
C. posadasii myceliaRa178505220 18,200 6460
Ra2559013,90014,10016,800
C. posadasii spherulesRa331002600 3430 3030
Ra47560597091106770
C. immitis myceliaRa513,2009920 20,200 11,100
Ra610,600881013,4009690
C. immitis spherulesRa 713,40011,60023,10012,400
Ra 812,0006770 9790 6560
Results are expressed as endpoint titers in ELISA × 10−3. Results are titers from sera of individual rabbits (n = 2 rabbits per immunization group). a Antisera were obtained from rabbits hyperimmunized with the indicated fungal cells. b ELISA plates were coated with the indicated, purified fungal mannans.
Table 3. Titer ratios showing cross-reactivity between Coccidioides mannans by ELISA.
Table 3. Titer ratios showing cross-reactivity between Coccidioides mannans by ELISA.
AntiserumMannan
Cp MyceliaCp SpherulesCi MyceliaCi Spherules
C. posadasii mycelia1.01.32.41.6
C. posadasii spherules1.21.01.41.1
C. immitis mycelia0.70.61.00.6
C. immitis spherules1.41.01.71.0
Titer ratios are calculated as (titer of serum against heterologous mannan)/(titer of serum against homologous mannan) [21]. Calculations based on geometric means from ELISA titers shown in Table 2.
Table 4. Antigenic relatedness between Coccidioides mannans by ELISA.
Table 4. Antigenic relatedness between Coccidioides mannans by ELISA.
AntiserumMannan
Cp MyceliaCp SpherulesCi MyceliaCi Spherules
C. posadasii mycelia1.0
C. posadasii spherules1.21.0
C. immitis mycelia1.30.91.0
C. immitis spherules1.51.01.01.0
Antigenic relatedness calculated from data in Table 2 using the method of Archetti and Horsfall.
Table 5. Antigenic relationship between cryptococcal serotypes A, B, and C, calculated from Evans [16].
Table 5. Antigenic relationship between cryptococcal serotypes A, B, and C, calculated from Evans [16].
Cross-reactivity between cryptococcal isolates by tube agglutination titers
AntiserumCells used for agglutination
Type AType BType C
Type A (RE)3204010
Type B (1523)32032010
Type C (LE)4040320
Titer ratios showing cross-reactivity between cryptococcal serotypes
AntiserumCells used for agglutination titers
Type AType BType C
Type A1.00.1250.03
Type B1.01.00.03
Type C0.1250.1251.0
Antigenic relationship between cryptococcal serotypes
Type AType BType C
Type A1.0
Type B0.351.0
Type C0.060.061.0
Agglutination titer data, as adapted from Evans [16]. Titer ratios were calculated from agglutination titers, as described in Table 3. Antigenic relationships were calculated, as illustrated in Table 4.
Table 6. Antigenic relationship between cryptococcal serotypes A, B, C, and D, calculated from Wilson, Bennett, and Bailey [17].
Table 6. Antigenic relationship between cryptococcal serotypes A, B, C, and D, calculated from Wilson, Bennett, and Bailey [17].
Cross-reactivity between cryptococcal isolates obtained by slide agglutination titers
AntiserumCells used for agglutination titers
Type AType BType CType D
Type A (68)102484128
Type B (112)10242048256512
Type C (18)1286412816
Type D (52)25625632256
Titer ratios showing cross-reactivity between cryptococcal serotypes
AntiserumCells used for agglutination titers
Type AType BType CType D
Type A1.00.0080.0040.125
Type B0.51.00.1250.25
Type C1.00.51.00.125
Type D1.01.00.1251.0
Antigenic relationship between cryptococcal isolates
Type AType BType CType D
Type A1.0
Type B0.061.0
Type C0.060.251.0
Type D0.350.50.1251.0
Agglutination titer data were adapted from Wilson, Bennett, and Bailey [17]. Titer ratios were calculated from agglutination titers, as described in Table 3. Antigenic relationships were calculated as illustrated in Table 4.
Table 7. Reactivity of antisera raised against C. posadasii and C. immitis mycelia and spherules with mannans of other fungi.
Table 7. Reactivity of antisera raised against C. posadasii and C. immitis mycelia and spherules with mannans of other fungi.
Antiserum bMannan Reactivity by ELISA (Reciprocal Titers × 10−3) a
Homologous
Cp or Ci
Mannan c
Af
4609
Fs
95-2478
Ca
2876
Ro
99-892
Ro
46599
Mc
8542
Mc
8097
C. posadasii mycelia663043217508051827115052
C. posadasii spherules3940361352010771218
C. immitis mycelia16,40039616404730425742115
C. immitis spherules9020133503102315617715
a Cp, C. posadasii; Ci, C. immitis; Af, Aspergillus fumigatus; Fs, Fusarium solani; Ca, Candida albicans; Ro, Rhizopus oryzae; Mc, Mucor circinelloides. Strain number is indicated for each fungus. b Antisera were obtained from rabbits hyperimmunized with the indicated Coccidioides cells. Results are the geometric mean of the sera of two rabbits. c Homologous mannan—ELISA was carried out using mannan from the immunizing antigen.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Burnham-Marusich, A.R.; Zayac, K.R.; Galgiani, J.N.; Lewis, L.; Kozel, T.R. Antigenic Relatedness between Mannans from Coccidioides immitis and Coccidioides posadasii Spherules and Mycelia. J. Fungi 2024, 10, 89. https://doi.org/10.3390/jof10020089

AMA Style

Burnham-Marusich AR, Zayac KR, Galgiani JN, Lewis L, Kozel TR. Antigenic Relatedness between Mannans from Coccidioides immitis and Coccidioides posadasii Spherules and Mycelia. Journal of Fungi. 2024; 10(2):89. https://doi.org/10.3390/jof10020089

Chicago/Turabian Style

Burnham-Marusich, Amanda R., Kathleen R. Zayac, John N. Galgiani, Lourdes Lewis, and Thomas R. Kozel. 2024. "Antigenic Relatedness between Mannans from Coccidioides immitis and Coccidioides posadasii Spherules and Mycelia" Journal of Fungi 10, no. 2: 89. https://doi.org/10.3390/jof10020089

APA Style

Burnham-Marusich, A. R., Zayac, K. R., Galgiani, J. N., Lewis, L., & Kozel, T. R. (2024). Antigenic Relatedness between Mannans from Coccidioides immitis and Coccidioides posadasii Spherules and Mycelia. Journal of Fungi, 10(2), 89. https://doi.org/10.3390/jof10020089

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop